BionX Reels in $17M in Funding

BionX Medical Technologies has reeled in $17 million in Series E funding led by Beijing-based ZGC Shiner Investment, along with existing investors.

The funding will support BionX’s expansion of its bionic prosthetic device business. The company’s flagship product, the BiOM Ankle, is the only lower-limb prosthesis with powered propulsion for enhanced mobility, according to BionX.

BionX plans to raise a total of $25 million in Series E financing by the end of the first quarter of 2016. — Michael Cipriano